Skip to content

Bulgari Donates Hand Sanitiser Gel to NHS Hospitals in the UK


Bvlgari is proud to announce the donation of over 160,000 units of medical-grade hand sanitising gel to the UK to be distributed throughout National Health Service [NHS] hospitals. This contribution will support the invaluable efforts of frontline medical staff to treat affected communities, whilst also keeping them as safe as possible from infection.

BVLGARI hand gel bottle

“Tackling coronavirus is a global effort. I'm grateful to Bvlgari, who have turned their capability to making vital protective hand gel. They are playing their part, helping people stay safe in these challenging times, and no doubt saving lives. I salute their generosity and the part they are playing in winning the battle against this virus.”
Matt Hancock, UK Secretary of State for Health and Social Care


“Bvlgari has immediately decided to refocus its industrial infrastructure to sanitising gels to protect heroic medical staff from Covid-19 infection. We started with our home country Italy as it was initially the most impacted country. Then we decided to extend our donation to Switzerland, one of the European countries with the highest number of infected people per million inhabitants. Now we further raise our donation to support the UK NHS, as the country now suffers from the highest daily death toll in Europe. I believe that a company is not only about maximising profits at any cost but also about behaving as a responsible citizen within its community, from daily ethical sourcing and sustainability initiatives to immediate reaction to contribute to natural disaster relief, from an earthquake in Nepal to an epidemic in the UK.”
Jean-Christophe Babin, Bvlgari CEO

Bvlgari’s fight against Covid-19 began with an important donation to the scientific community in February, specifically to the Spallanzani Hospital in Rome. One month later, Bvlgari converted its fragrance production to manufacture hand sanitising gel. This has been donated to medical facilities across Italy and Switzerland, and will now be distributed in the UK to the NHS.